Replies to post #23734 on Seelos Therapeutics Inc (SEEL)

[carlodb1978]

I think they take the quotation of the June, when they did the report, not the price they paid.

Price paid is 1,82 this year + warrant at the same price.

So, they own about 12% + an extra potential 5%.

They should raise extra cash or what can also happen is that Sarissa will push for a financing with Vitaros as guarantee as suggested by Eicoman.

So, soon or later we will hear about the cash raise. At this point should be after the conf call for the Q3